Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
50.00
0.00 (0.00%)
Oct 27, 2026, 9:14 AM JST

Chordia Therapeutics Cash Flow Statement

Millions JPY. Fiscal year is Sep - Aug.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Net Income
-1,455-1,786-1,827223.34
Depreciation & Amortization
-2.74.096.04
Asset Writedown & Restructuring Costs
2.613.78--
Other Operating Activities
45.69128.24-224.68229.54
Change in Other Net Operating Assets
-11.67-195.77110.4684.81
Operating Cash Flow
-1,419-1,837-1,937543.73
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Capital Expenditures
-2.6-5.33-0.54-0.35
Sale (Purchase) of Intangibles
----0.38
Other Investing Activities
0.32--10.421.07
Investing Cash Flow
-2.28-5.33-10.960.35

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Issuance of Common Stock
927.4761.581,479-
Other Financing Activities
-3.34---
Financing Cash Flow
924.1361.581,479-

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Miscellaneous Cash Flow Adjustments
0-0-00
Net Cash Flow
-496.68-1,781-469.41544.08

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Free Cash Flow
-1,421-1,842-1,938543.38
Free Cash Flow Growth
----
Free Cash Flow Margin
---21.73%
Free Cash Flow Per Share
-19.28-26.85-32.999.63
Levered Free Cash Flow
-909.27-1,192-1,243-
Unlevered Free Cash Flow
-909.27-1,192-1,243-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Cash Income Tax Paid
2.422.422.422.42
Change in Working Capital
-11.67-195.77110.4684.81